225 related articles for article (PubMed ID: 32583691)
1. Cinacalcet-Associated Resolution of Primary Hyperparathyroidism in a Patient With Normal Kidney Function.
Nguyen S; Gosmanova EO; Gosmanov AR
J Investig Med High Impact Case Rep; 2020; 8():2324709620936836. PubMed ID: 32583691
[TBL] [Abstract][Full Text] [Related]
2. A Randomized Study Comparing Parathyroidectomy with Cinacalcet for Treating Hypercalcemia in Kidney Allograft Recipients with Hyperparathyroidism.
Cruzado JM; Moreno P; Torregrosa JV; Taco O; Mast R; Gómez-Vaquero C; Polo C; Revuelta I; Francos J; Torras J; García-Barrasa A; Bestard O; Grinyó JM
J Am Soc Nephrol; 2016 Aug; 27(8):2487-94. PubMed ID: 26647424
[TBL] [Abstract][Full Text] [Related]
3. Cinacalcet as symptomatic treatment of hypercalcaemia in primary hyperparathyroidism prior to surgery.
Misiorowski W; Zgliczyński W
Endokrynol Pol; 2017; 68(3):306-310. PubMed ID: 28660989
[TBL] [Abstract][Full Text] [Related]
4. Cinacalcet for the treatment of primary hyperparathyroidism.
Dillon ML; Frazee LA
Am J Ther; 2011 Jul; 18(4):313-22. PubMed ID: 20228675
[TBL] [Abstract][Full Text] [Related]
5. Treatment of Persistent Hypercalcemia and Hyperparathyroidism With Cinacalcet After Successful Kidney Transplantation.
Ważna-Jabłońska E; Gałązka Z; Durlik M
Transplant Proc; 2016 Jun; 48(5):1623-5. PubMed ID: 27496458
[TBL] [Abstract][Full Text] [Related]
6. Cinacalcet HCl reduces hypercalcemia in primary hyperparathyroidism across a wide spectrum of disease severity.
Peacock M; Bilezikian JP; Bolognese MA; Borofsky M; Scumpia S; Sterling LR; Cheng S; Shoback D
J Clin Endocrinol Metab; 2011 Jan; 96(1):E9-18. PubMed ID: 20943783
[TBL] [Abstract][Full Text] [Related]
7. Prediction of cognitive response to surgery in elderly patients with primary hyperparathyroidism.
Koman A; Bränström R; Pernow Y; Bränström R; Nilsson IL
BJS Open; 2021 Mar; 5(2):. PubMed ID: 33724336
[TBL] [Abstract][Full Text] [Related]
8. Primary Hyperparathyroidism Manifesting with Severe Hypercalcemia in a Nonagenarian Man: Pitfall of Common Imaging Techniques, Localization by 18F-Choline Positron Emission Tomography/Computed Tomography and Successful Management with Calcimimetics.
Foppiani L; Bottoni G; Piccardo A
Acta Medica (Hradec Kralove); 2019; 62(4):156-160. PubMed ID: 32036848
[TBL] [Abstract][Full Text] [Related]
9. Effect of Cinacalcet in Kidney Transplant Patients With Hyperparathyroidism.
Jo HA; Han KH; So YK; Jun H; Han SY
Transplant Proc; 2019 Jun; 51(5):1397-1401. PubMed ID: 31155177
[TBL] [Abstract][Full Text] [Related]
10. Impact of cinacalcet hydrochloride in clinical management of primary hyperparathyroidism in multiple endocrine neoplasia type 1.
Del Prete M; Marotta V; Ramundo V; Marciello F; Di Sarno A; Esposito R; Carratù AC; De Luca Di Roseto C; Di Somma C; Colao A; Faggiano A
Minerva Endocrinol; 2013 Dec; 38(4):389-94. PubMed ID: 24285106
[TBL] [Abstract][Full Text] [Related]
11. Cinacalcet as alternative treatment for primary hyperparathyroidism: achievements and prospects.
Duntas LH; Stathatos N
Endocrine; 2011 Jun; 39(3):199-204. PubMed ID: 21442382
[TBL] [Abstract][Full Text] [Related]
12. Long-term results of a randomized study comparing parathyroidectomy with cinacalcet for treating tertiary hyperparathyroidism.
Moreno P; Coloma A; Torregrosa JV; Montero N; Francos J; Codina S; Manonelles A; Bestard O; García-Barrasa A; Melilli E; Cruzado JM
Clin Transplant; 2020 Aug; 34(8):e13988. PubMed ID: 32438479
[TBL] [Abstract][Full Text] [Related]
13. Management of Primary Hyperparathyroidism With Severe Hypercalcemia During the COVID-19 Pandemic.
Alfadhli EM
Clin Ther; 2021 Apr; 43(4):711-719. PubMed ID: 33752899
[TBL] [Abstract][Full Text] [Related]
14. Cinacalcet hydrochloride relieves hypercalcemia in Japanese patients with parathyroid cancer and intractable primary hyperparathyroidism.
Takeuchi Y; Takahashi S; Miura D; Katagiri M; Nakashima N; Ohishi H; Shimazaki R; Tominaga Y
J Bone Miner Metab; 2017 Nov; 35(6):616-622. PubMed ID: 27873072
[TBL] [Abstract][Full Text] [Related]
15. Clinical utilization of cinacalcet in hypercalcemic conditions.
Messa P; Alfieri C; Brezzi B
Expert Opin Drug Metab Toxicol; 2011 Apr; 7(4):517-28. PubMed ID: 21361849
[TBL] [Abstract][Full Text] [Related]
16. Use of cinacalcet in nephrolithiasis associated with normocalcemic or hypercalcemic primary hyperparathyroidism: results of a prospective randomized pilot study.
Brardi S; Cevenini G; Verdacchi T; Romano G; Ponchietti R
Arch Ital Urol Androl; 2015 Mar; 87(1):66-71. PubMed ID: 25847900
[TBL] [Abstract][Full Text] [Related]
17. Short-term medical treatment of hypercalcaemia in primary hyperparathyroidism predicts symptomatic response after parathyroidectomy.
Koman A; Ohlsson S; Bränström R; Pernow Y; Bränström R; Nilsson IL
Br J Surg; 2019 Dec; 106(13):1810-1818. PubMed ID: 31595982
[TBL] [Abstract][Full Text] [Related]
18. Transient hypercortisolism and symptomatic hyperthyroidism associated to primary hyperparathyroidism in an elderly patient: case report and literature review.
Sabbadin C; Donà G; Bordin L; Iacobone M; Camozzi V; Mian C; Armanini D
BMC Endocr Disord; 2015 Jan; 15():4. PubMed ID: 25631825
[TBL] [Abstract][Full Text] [Related]
19. Benefits and place of calcimimetics in the management of primary hyperparathyroidism.
Meier C
Ann Endocrinol (Paris); 2015 May; 76(2):163-4. PubMed ID: 25913524
[No Abstract] [Full Text] [Related]
20. Hypercalcemia of primary hyperparathyroidism was treated by cinacalcet in a patient with liver cirrhosis.
Akinci B; Comlekci A; Tankurt E
Exp Clin Endocrinol Diabetes; 2009 Mar; 117(3):142-5. PubMed ID: 18561096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
